1 An interview with Mark Corbett on the new UK Early Access to Medicine Scheme
event strap

An interview with Mark Corbett on the new UK Early Access to Medicine Scheme

information we require

please check before submitting



Unfortunately the document is not available at this current time, however if you leave your details we'll get it to you as soon as we can.

Please fill in all the information requested. It is very important you enter this information correctly so we can contact you with the document.

Privacy statement »

Manage your email preferences »

Remember my details Information

Information
Remember my details
We place a 'cookie' on your computer so next time you visit us you don't need to fill in all these details

Mark Corbett, Senior Vice President of Clinigen Global Access Programs discusses the UK’s Early Access to Medicines Scheme

 

In March 2014, the UK Early Access to Medicines Scheme was launched, and within two weeks an Adaptive Licencing initiative was launched by the European Medicines Agency (EMA). These programmes present opportunities to enable earlier drug access to the market, giving patients with rare diseases quicker access to potentially life saving drugs.
 
In this report we speak with Mark Corbett, Senior Vice President of Clinigen Global Access Programs, about the UK EAMS and recommendations to enable greater access to drugs for those with rare diseases

Download the report now to:

  • Hear Mark's opinion on whether or not EAMS is a positive move forward, and how it will develop in the next few years
  • Gain an insight into how the UK currently rates in comparison with other global access programmes
  • Understand if enough is currently being done both within the UK and further afield to provide those with rare diseases adequate access to potentially lifesaving drugs
  • Discover Mark's top five recommendations for moving forward to enable greater access to drugs for those with rare diseases
  • Learn more about Mark, and how Clinigen Global Access Programs fits into the orphan drug space

Join us in London on the 10th July at the Fast Tracking Orphan Drugs Briefing to learn how new developments will speed up orphan drug market access. Download the Ebook to gain your 10% discount. Book now!